Dr. David Edwin Burdette, MD

Dr. Burdette practices at Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health.

Dr. Burdette's NPI, 1679648315, was assigned on November 21, 2006. Dr. Burdette graduated from Boston University School Of Medicine in 1986. Dr. Burdette holds Michigan license 4301056700.

Dr. Burdette's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth, at 100 Michigan St NE, Grand Rapids, MI 49503 in Kent County. The practice phone is (616) 391-1774.

Dr. Burdette's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health. Dr. Burdette is also affiliated with Bronson Methodist Hospital. The medical group on file is Corewell Health Medical Group West. Dmand AI also links Dr. Burdette to 3 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Burdette practices, 8 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Burdette's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Burdette is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Burdette's licenses on file in 2 states: Michigan and Ohio.

Dmand AI lists epilepsy and seizures among the conditions Dr. Burdette treats.

CMS data shows 334 Medicare services from Dr. Burdette across 5 procedure codes in 2024, for 204 Medicare patients. Medicare paid $38,626 for them.

CMS counts 204 Medicare patients who saw Dr. Burdette in 2024. The largest group is under 65, with 78 patients. 67% of them have high blood pressure, and 65% have high cholesterol. 43% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Burdette's median patient age at 49, with 53% women.

In 2024, Dr. Burdette wrote 3,303 Medicare Part D claims for 222 patients. 62% of them were for generic drugs. CMS names the drug for 3,162 of them, across 37 drugs with 11 or more claims each, at $3,597,799 in total drug cost. In 2023, CMS named 3,235 claims across 39 drugs.

Dr. Burdette accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Burdette as offering telehealth.

Dmand AI links 22 papers to Dr. Burdette, published from 2012 to 2024. 2021 was the busiest year, with 2. The most frequent topics are Electroencephalography, Drug Resistant Epilepsy and Epilepsy. Dr. Burdette has published most often in Epilepsia Open. Dr. Burdette's most frequent co-authors are Sanjay Earl Patra, MD, James Chris Sackellares, MD and Konstantin Volod Elisevich, MD.

CMS Open Payments shows 2,310 general payments to Dr. Burdette from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. UCB, Inc. paid the most, $913,603. It also lists 821 research payments totaling $417,314 from 2016 to 2025.

Dr. Burdette graduated from Boston University School Of Medicine in 1986.

Dr. Burdette is in network with 12 carriers, including Aetna, Health Alliance Plan and Priority Health. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.